Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

Summary:  There are now many experimental models of inflammatory bowel disease (IBD), most of which are due to induced mutations in mice that result in an impaired homeostasis with the intestinal microbiota. These models can be clustered into several broad categories that, in turn, define the crucial cellular and molecular mechanisms of host microbial interactions in the intestine. The first of these components is innate immunity defined broadly to include both myeloid and epithelial cell mechanisms. A second component is the effector response of the adaptive immune system, which, in most instances, comprises the CD4+ T cell and its relevant cytokines. The third component is regulation, which can involve multiple cell types, but again particularly involves CD4+ T cells. Severe impairment of a single component can result in disease, but many models demonstrate milder defects in more than one component. The same is true for both spontaneous models of IBD, C3H/HeJBir and SAMPI/Yit mice. The thesis is advanced that ‘multiple hits’ or defects in these interacting components is required for IBD to occur in both mouse and human.

[1]  Agneta Karlsson,et al.  Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[2]  M. Abreu,et al.  TLR Signaling in the Gut in Health and Disease1 , 2005, The Journal of Immunology.

[3]  S. Cohn,et al.  Altered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice. , 2005, The American journal of pathology.

[4]  K. Barrett,et al.  Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[5]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[6]  D. Haller,et al.  IL-10 Gene-Deficient Mice Lack TGF-β/Smad Signaling and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells after the Colonization with Colitogenic Enterococcus faecalis1 , 2005, The Journal of Immunology.

[7]  F. Cominelli,et al.  Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. , 2005, Gastroenterology.

[8]  S. Miura,et al.  Blockade of PSGL‐1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice , 2005, Journal of leukocyte biology.

[9]  J. Braun,et al.  Surveillance B lymphocytes and mucosal immunoregulation , 2005, Springer Seminars in Immunopathology.

[10]  K. Ley,et al.  L-Selectin, α4β1, and α4β7 Integrins Participate in CD4+ T Cell Recruitment to Chronically Inflamed Small Intestine1 , 2005, The Journal of Immunology.

[11]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[12]  Michael Karin,et al.  Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.

[13]  C. Jobin,et al.  STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells , 2005 .

[14]  J. Orenstein,et al.  Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. , 2005, The Journal of clinical investigation.

[15]  K. H. Banner,et al.  Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene , 2004, British journal of pharmacology.

[16]  P. Pavli,et al.  NOD2 mutations and Crohn’s disease: are Paneth cells and their antimicrobial peptides the link? , 2004, Gut.

[17]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[18]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[19]  Tetsuya Nakamura,et al.  CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells1 , 2004, The Journal of Immunology.

[20]  B. Mannervik,et al.  Selective expression of detoxifying glutathione transferases in mouse colon: effect of experimental colitis and the presence of bacteria , 2004, Histochemistry and Cell Biology.

[21]  S. Sakaguchi,et al.  Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. , 2004, International immunology.

[22]  Tomohiro Watanabe,et al.  NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.

[23]  K. Ley,et al.  Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. , 2004, The Journal of clinical investigation.

[24]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[25]  S. Wahl,et al.  Aberrant Toll Receptor Expression and Endotoxin Hypersensitivity in Mice Lacking a Functional TGF-β1 Signaling Pathway , 2004, The Journal of Immunology.

[26]  A. Macpherson,et al.  Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria , 2004, Science.

[27]  S. Akira,et al.  Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. , 2004, Gastroenterology.

[28]  P. Murray,et al.  Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists , 2003, Molecular and Cellular Biology.

[29]  Judy H. Cho,et al.  Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis , 2003, Gut.

[30]  J. Fox,et al.  NF-κB Is Required Within the Innate Immune System to Inhibit Microflora-Induced Colitis and Expression of IL-12 p401 , 2003, The Journal of Immunology.

[31]  S. Davies,et al.  Crohn's disease and the NOD2 gene: a role for paneth cells. , 2003, Gastroenterology.

[32]  K. Fellermann,et al.  Crohn's disease: a defensin deficiency syndrome? , 2003, European journal of gastroenterology & hepatology.

[33]  J. Satsangi,et al.  Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? , 2003, Gut.

[34]  C. Elson,et al.  The dominant immune response to intestinal bacterial antigens is ignorance, rather than tolerance , 2003 .

[35]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[36]  E. Fikrig,et al.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Ishikawa,et al.  Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. , 2003, Microbes and infection.

[38]  G. Kollias,et al.  Genetic Dissection of the Cellular Pathways and Signaling Mechanisms in Modeled Tumor Necrosis Factor–induced Crohn's-like Inflammatory Bowel Disease , 2002, The Journal of experimental medicine.

[39]  C. Elson,et al.  Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora1 , 2002, The Journal of Immunology.

[40]  G. Warhurst,et al.  Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(−/−) Mouse Intestine , 2002, Journal of Pharmacology and Experimental Therapeutics.

[41]  R. Blumberg,et al.  Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. , 2002, Immunity.

[42]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[43]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[44]  Lillian Maggio-Price,et al.  Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. , 2002, The American journal of pathology.

[45]  R. Blumberg,et al.  Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. , 2002, Immunity.

[46]  C. Elson,et al.  T Helper 1 and T Helper 2 Cells Are Pathogenic in an Antigen-specific Model of Colitis , 2002, The Journal of experimental medicine.

[47]  C. Moskaluk,et al.  Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. , 2001, Gastroenterology.

[48]  A. Munakata,et al.  Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease , 2001, Journal of gastroenterology and hepatology.

[49]  S. Kitajima,et al.  Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. , 2001, Experimental animals.

[50]  E. Shevach,et al.  Control of T‐cell activation by CD4+ CD25+ suppressor T cells , 2001, Immunological reviews.

[51]  Sayuri Yamazaki,et al.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.

[52]  T. Druley,et al.  From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance , 2001, Cellular and Molecular Life Sciences CMLS.

[53]  S. Wahl,et al.  TGF-β Released by Apoptotic T Cells Contributes to an Immunosuppressive Milieu , 2001 .

[54]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[55]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[56]  J. Schölmerich,et al.  Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice , 2001, Infection and Immunity.

[57]  C. Moskaluk,et al.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. , 2001, The Journal of clinical investigation.

[58]  J. Reimann,et al.  Enteric bacterial antigens activate CD4+ T cells from scid mice with inflammatory bowel disease , 2001, European journal of immunology.

[59]  R. Lorenz,et al.  The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota , 2001, Cellular microbiology.

[60]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[61]  R L Hunter,et al.  Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. , 2000, Life sciences.

[62]  Harriman,et al.  Immune Activation in the Intestinal Mucosa Before the Onset of Colitis in Gαi2‐Deficient Mice , 2000, Scandinavian journal of immunology.

[63]  J. Chen,et al.  Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis. , 2000, Gastroenterology.

[64]  A. Cumano,et al.  Regulatory CD4 T Cells Control the Size of the Peripheral Activated/Memory CD4 T Cell Compartment1 , 2000, The Journal of Immunology.

[65]  A. Blum,et al.  Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice , 2000, Clinical and experimental immunology.

[66]  M. Kronenberg,et al.  Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis. , 2000, Journal of immunology.

[67]  U. Brinkmann,et al.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Flavell,et al.  Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .

[69]  M. Neurath,et al.  TNBS-Colitis , 2000, International reviews of immunology.

[70]  D. Podolsky,et al.  A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. , 1999, The Journal of clinical investigation.

[71]  T. Walle,et al.  Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. , 1999, Carcinogenesis.

[72]  Fiona Powrie,et al.  An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation , 1999, The Journal of experimental medicine.

[73]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[74]  W. Maksymowych,et al.  Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis. , 1999, Human immunology.

[75]  R. N. Smith,et al.  Colitis in transgenic and knockout animals as models of human inflammatory bowel disease , 1999, Immunological reviews.

[76]  H. Ziegler-Heitbrock,et al.  NF-κB1 (p50) Is Upregulated in Lipopolysaccharide Tolerance and Can Block Tumor Necrosis Factor Gene Expression , 1999, Infection and Immunity.

[77]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[78]  M. Neurath,et al.  Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. , 1999, Journal of immunology.

[79]  S. Kitajima,et al.  Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. , 1999, The Journal of veterinary medical science.

[80]  Samir A. Shah,et al.  Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. , 1998, Gastroenterology.

[81]  W. Strober,et al.  Oxazolone Colitis: A Murine Model of  T Helper Cell Type 2 Colitis Treatable with Antibodies to Interleukin 4 , 1998, The Journal of experimental medicine.

[82]  J. C. Jones,et al.  References Subscriptions Permissions Email Alerts A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis , 2013 .

[83]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[84]  M. Leach,et al.  A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. , 1998, Journal of immunology.

[85]  M. Leach,et al.  IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. , 1998, Journal of immunology.

[86]  A. Imaoka,et al.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain , 1998, Gut.

[87]  C. Pénit,et al.  Regulatory Cd4 T Cells: Expression of Il-2rα Chain, Resistance to Clonal Deletion and Il-2 Dependency , 1998 .

[88]  J. Sundberg,et al.  CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease , 1998, The Journal of experimental medicine.

[89]  J. Sundberg,et al.  Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[90]  M. Wasik,et al.  Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. , 1998, Journal of immunology.

[91]  F. Preffer,et al.  Suppressive Role of B Cells in Chronic Colitis of  T Cell Receptor α Mutant Mice , 1997, The Journal of experimental medicine.

[92]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[93]  B. Ludviksson,et al.  TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. , 1997, Journal of immunology.

[94]  H. Haugen,et al.  Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. , 1997, International immunology.

[95]  C. Elson,et al.  Single‐cell analyses of CD4+ T cells from αβ T cell receptor‐transgenic mice: a distinct mucosal cytokine phenotype in the absence of transgene‐specific antigen , 1997 .

[96]  J. Sundberg,et al.  Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. , 1997, Journal of immunology.

[97]  G. Boivin,et al.  Germ-free and barrier-raised TGFβ1-deficient mice have similar inflammatory lesions , 1997, Transgenic Research.

[98]  S. Targan,et al.  Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. , 1997, Journal of immunology.

[99]  N. Davidson,et al.  Studies with IL‐10‐/‐ mice: an overview , 1997, Journal of leukocyte biology.

[100]  J. Rhodes Mucins and inflammatory bowel disease. , 1997, QJM : monthly journal of the Association of Physicians.

[101]  B. Ludviksson,et al.  Induction and prevention of colonic inflammation in IL-2-deficient mice. , 1997, Journal of immunology.

[102]  A. Kulkarni,et al.  Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. , 1996, The Journal of clinical investigation.

[103]  M. Leach,et al.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.

[104]  E. Mizoguchi,et al.  Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice , 1996, The Journal of experimental medicine.

[105]  R. Coffman,et al.  A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.

[106]  M. Neurath,et al.  Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance , 1996, The Journal of experimental medicine.

[107]  R. Coffman,et al.  Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. , 1996, The American journal of pathology.

[108]  C. Janeway,et al.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[109]  M. Yin,et al.  Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[110]  A. Schimpl,et al.  Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene , 1995, The Journal of experimental medicine.

[111]  A. Bradley,et al.  Gi2α protein deficiency: A model for inflammatory bowel disease , 1995, Journal of Clinical Immunology.

[112]  R. Noelle,et al.  Generalized autoimmune disease in interleukin‐2‐deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells , 1995, European journal of immunology.

[113]  M. Datta,et al.  T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice , 1995, The Journal of experimental medicine.

[114]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[115]  D. Allen,et al.  Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin‐2‐deficient colitis , 1995, European journal of immunology.

[116]  C. Elson,et al.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.

[117]  J. Sundberg,et al.  Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. , 1994, Gastroenterology.

[118]  K. Murphy,et al.  Heterogeneity of single cell cytokine gene expression in clonal T cell populations , 1994, The Journal of experimental medicine.

[119]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[120]  T. Midtvedt,et al.  Experimental Colitis Induced by Dextran Sulphate in Normal and Germfree Mice , 1994 .

[121]  T. Grogan,et al.  P-glycoprotein expression and function in circulating blood cells from normal volunteers. , 1994, Blood.

[122]  R. Sartor,et al.  Mechanisms of acute and chronic intestinal inflammation induced by indomethacin , 1993, Inflammation.

[123]  R. Zinkernagel,et al.  Immune responses in interleukin-2-deficient mice. , 1993, Science.

[124]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[125]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[126]  T. Tsuruo,et al.  Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.

[127]  J. Watson,et al.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.

[128]  T. Ohkusa,et al.  Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. , 1992, Gut.

[129]  M. Grilli,et al.  NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. , 1992, Science.

[130]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[131]  S. Wahl,et al.  Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta , 1988, The Journal of experimental medicine.

[132]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[133]  W. J. Cromartie,et al.  Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. , 1985, Gastroenterology.

[134]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[135]  Rudi Beyaert,et al.  A20 inhibits NF-κB activation by dual ubiquitin-editing functions , 2005 .

[136]  K. Ley,et al.  L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine. , 2005, Journal of immunology.

[137]  R. Beyaert,et al.  A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. , 2005, Trends in biochemical sciences.

[138]  Shizuo Akira,et al.  MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis , 2004, Journal of Gastroenterology.

[139]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.

[140]  U. Brinkmann,et al.  Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. , 2003, Gastroenterology.

[141]  S. Sakaguchi,et al.  The role of regulatory T cells in controlling immunologic self-tolerance. , 2003, International review of cytology.

[142]  S. Targan,et al.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. , 2002, Gastroenterology.

[143]  S. Wahl,et al.  TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. , 2001, Immunity.

[144]  R. Flavell,et al.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. , 2000, Immunity.

[145]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[146]  H. Gaskins,et al.  Probiotics and the immune system. , 1999 .

[147]  A. Hayday,et al.  T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. , 1997, The American journal of pathology.

[148]  C. Elson,et al.  Single-cell analyses of CD4+ T cells from alpha beta T cell receptor-transgenic mice: a distinct mucosal cytokine phenotype in the absence of transgene-specific antigen. , 1997, European journal of immunology.

[149]  A. Kulkarni,et al.  Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. , 1995, The American journal of pathology.

[150]  T. Ohkusa,et al.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. , 1990, Gastroenterology.

[151]  F. Powrie,et al.  Brief Definitive Report Cytotoxic T Lymphocyte–associated Antigen 4 Plays an Essential Role in the Function of Cd25 Ϩ Cd4 Ϩ Regulatory Cells That Control Intestinal Inflammation , 2022 .